Lymphoma, Large Cell Completed Phase 1 / 2 Trials for SGN-30 (DB05471)

Also known as: Large Cell Lymphoma / Lymphoma, Large-Cell / Large-cell Lymphoma

IndicationStatusPhase
DBCOND0032452 (Lymphoma, Large Cell)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00051597A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic MalignanciesTreatment